Condition
Lyme Arthritis
Total Trials
6
Recruiting
0
Active
0
Completed
1
Success Rate
33.3%-53% vs avg
Key Insights
Highlights
Success Rate
33% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 65/100
Termination Rate
33.3%
2 terminated out of 6 trials
Success Rate
33.3%
-53.2% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results33% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 3 (1)
Trial Status
Terminated2
Unknown1
Completed1
Suspended1
Not Yet Recruiting1
Trial Success Rate
33.3%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07351721Not Yet RecruitingPrimary
Borrelia Arthritis - a Hidden Cause of Arthritis in Danish Patients?
NCT04038346Phase 3TerminatedPrimary
Symptomatic Management of Lyme Arthritis
NCT04031469Suspended
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
NCT04577053Not ApplicableTerminated
PEMF Therapy to Treat Lingering Symptoms of Lyme Disease After Treatment With Antibiotics
NCT03505879Completed
Next Generation Sequencing Detection of Lyme Disease
NCT03510507UnknownPrimary
Characteristics of Lyme Arthritis
Showing all 6 trials